IVD Manufacturers, Labs Should Be Subject To Same Standards – AdvaMed

FDA should allow in vitro diagnostic manufacturers to partake of some of the same regulatory flexibility that clinical labs currently enjoy, AdvaMed suggests to HHS in 1Aug. 23 comments on stimulating medical technology innovation